慢性鼻窦炎短期药物治疗中生活质量和嗅觉变化观察
本研究前瞻性纳入有症状的慢性鼻窦炎成人患者,采用个体化标准药物治疗约7.8周,观察到SNOT-22总分中位改善39.5%(n=39,p<0.001),嗅觉专项生活质量QOD-NS亦有统计学显著改善(p=0.044),但Sniffin' Sticks嗅觉功能评分相对改善10.9%(n=33,p=0.109)未达统计学显著。
要点
- 短期个体化药物治疗可显著改善CRS患者生活质量和嗅觉相关生活质量。
- 主观嗅觉生活质量改善不伴随客观嗅觉功能测试的显著改善。
- 客观嗅觉功能变化与内镜评分中度相关,但与生活质量评分无关联。
核心结论
- 个体化短期标准药物治疗可显著改善CRS患者疾病相关及嗅觉相关生活质量,但未观察到客观嗅觉功能的显著改善。
- 客观嗅觉功能变化与内镜评分变化中度相关,但与生活质量测量无关联。
研究设计与样本
- 前瞻性、观察性、多机构研究,纳入有症状的慢性鼻窦炎成人患者。
- 在入组时和随访时进行内镜检查(Lund-Kennedy)、嗅觉功能测试(Sniffin' Sticks)和生活质量问卷(SNOT-22、QOD-NS)。
主要发现
- 基线时生活质量和嗅觉功能障碍存在异质性。
- 平均7.8周后,SNOT-22总分中位相对基线改善39.5%(n=39,p<0.001)。
- SNOT-22第21项「嗅觉/味觉」改善50%(p=0.014)。
- QOD-NS改善具有统计学显著性(p=0.044)。
- Sniffin' Sticks评分相对改善10.9%(n=33,p=0.109),未达统计学显著,且与SNOT-22总分(R=-0.247,p=0.165)或QOD-NS总分(R=-0.016,p=0.930)无相关性,但与内镜评分中度相关(R=-0.436,p=0.018)。
临床怎么用
- 对于有症状的CRS患者,短期个体化标准药物治疗可改善主观生活质量和嗅觉相关生活质量。
- 客观嗅觉功能测试的改善可能滞后于主观感受,临床评估需结合主观问卷和客观检查。
局限性
- 样本量较小(SNOT-22分析n=39,Sniffin' Sticks分析n=33)。
- 观察性研究设计,缺乏对照组。
- 随访时间较短(平均7.8周)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic rhinosinusitis (CRS) commonly experience both reduced quality of life (QOL) and olfactory dysfunction (OD). Literature on the impacts of appropriate medical therapy (AMT) for CRS on QOL and OD is limited, and the focused design of these studies may limit their applicability to usual clinical practice. METHODS: Adults with symptomatic CRS were prospectively enrolled (November 2016 to October 2018) into an observational, multi-institutional study. Individualized AMT was initiated using standard practice according to evidence-based guidelines. Endoscopy examination (Lund-Kennedy), olfactory function (Sniffin' Sticks) testing, and QOL survey responses (22-item Sino-Nasal Outcome Test [SNOT-22], Questionnaire of Olfactory Disorders-Negative Statements [QOD-NS]) were obtained at enrollment and follow-up. RESULTS: Baseline measures demonstrated heterogeneity of QOL and OD. After an average of 7.8 weeks, within-subject median SNOT-22 total improved by 39.5% (n = 39, p < 0.001) relative to baseline, including 50% (p = 0.014) improvement for item #21, "Sense of smell/taste." QOD-NS improvement was also statistically significant (p = 0.044). Sniffin' Sticks score relative improvement of 10.9% (n = 33, p = 0.109) was not statistically significant and lacked correlation with SNOT-22 total scores (R = -0.247, p = 0.165) or QOD-NS total scores (R = -0.016, p = 0.930), but correlated moderately with endoscopy score (R = -0.436, p = 0.018). CONCLUSIONS: Participants with varied impacts of CRS, treated with individualized short-term AMT, demonstrated significant improvements in CRS- and olfactory-specific QOL measures, without corresponding improvement in clinically measured olfactory function. Olfactory function changes moderately correlated with endoscopy score changes, but lacked an association with QOL measurements.
引用
- Thomas AJ, Mace JC, Ramakrishnan VR, et al. Quality-of-life and olfaction changes observed with short-term medical management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020. PMID: 32017433. doi:10.1002/alr.22532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。